Product Information
CEPHALEXIN 500 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1210 per EA under NDC 65862001940. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Nov 16, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Cephalexin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862001940
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEPHALEXINApproval Type
Generic (ANDA)
FDA Application
ANDA065253FDA Approved
11/16/2005
TE Code
AB
On Market Since
11/16/2005
Pharmacological Classes
Price Statistics
The NADAC for CEPHALEXIN 500 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 13.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1210 per EA |
|---|---|
| All-time high | $0.1576 (Jan 10, 2024) |
| All-time low | $0.0821 (Sep 21, 2016) |
| 52-week high | $0.1313 |
| 52-week low | $0.1204 |
| Median price | $0.1103 |
| Average price | $0.1094 |
| Largest weekly change | -30.2% (Nov 20, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEPHALEXIN 500 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEPHALEXIN 500 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.1210 per EA (NDC 65862001940), effective Aug 19, 2026.
How has the price of CEPHALEXIN 500 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEPHALEXIN 500 MG CAPSULE has risen 13.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEPHALEXIN 500 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CEPHALEXIN 500 MG CAPSULE has ranged from a low of $0.0821 (Sep 21, 2016) to a high of $0.1576 (Jan 10, 2024), with a median of $0.1103 per EA.
Are there cheaper alternatives to CEPHALEXIN 500 MG CAPSULE?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEPHALEXIN 500 MG CAPSULE, is $0.0924 per EA — about 24% below CEPHALEXIN 500 MG CAPSULE.
Who manufactures CEPHALEXIN 500 MG CAPSULE?
CEPHALEXIN 500 MG CAPSULE (NDC 65862001940) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.